99mTc-MAG3 scintigraphy for the longitudinal follow-up of kidney function in a mouse model of renal ischemia-reperfusion injury
© Herrler et al; licensee Springer. 2012
Received: 12 December 2011
Accepted: 20 January 2012
Published: 20 January 2012
Experimental models are essential tools in the development and evaluation of novel treatment options, but the preclinical model of renal ischemia-reperfusion injury is limited to the retrieval of (very) early functional data, leaving the pivotal long-term outcome unknown. The present study applies technetium-99m-mercapto-acetyl-tri-glycine [99mTc-MAG3] scintigraphy for the longitudinal follow-up examination of long-term kidney function after renal ischemia-reperfusion injury.
Unilateral warm ischemia was induced in scid beige mice by vascular clamping of the kidney hilum for 40 min. 99mTc-MAG3 scintigraphy was performed prior to injury, 8 and 14 days post ischemia. The fractional uptake rate [FUR] was calculated from scintigraphy data as a measure of renal clearance.
FUR demonstrated a significant functional impairment of the ischemic kidney 8 and 14 days after injury (P < 0.05 vs. baseline), while contralateral non-ischemic kidneys showed no significant changes. In histological analysis, ischemic kidneys exhibited tubular dilatation and cytoplasmic degeneration as signs of hypoxia without any evidence for necrosis.
FUR enables the detection of renal dysfunction and longitudinal long-term follow-up examination in the same individual. Our model may facilitate preclinical therapy evaluation for the identification of effective renoprotective therapies.
Following kidney transplantation, renal ischemia-reperfusion injury contributes to allograft dysfunction and loss. Promising experimental results have failed to translate into therapies for clinical use. This may be partly explained by methodological limitations in the experimental setting. In the preclinical model of renal ischemia-reperfusion injury, functional data based on standard biochemical parameters can only be obtained in the acute phase of injury [1, 2]. Specifically, serum creatinine levels were shown to represent a valid indicator of renal dysfunction only during the early post-ischemic period of 24 to 72 h .
Dynamic scintigraphy using the radioactive compound technetium-99m-mercapto-acetyl-tri-glycine [99mTc-MAG3] was recently introduced as a technique for the determination of early functional changes in a murine model of renal ischemia-reperfusion injury . The aim of the present study was to apply 99mTc-MAG3 imaging for longitudinal follow-up studies of early and, most importantly, long-term kidney function after injury. The fractional uptake rate [FUR] was calculated in analogy to studies in humans [5, 6] as a measure of renal clearance using a modified protocol and enabled us to collect valuable information on individual long-term changes. To demonstrate the high accuracy and sensitivity of 99mTc-MAG3 scintigraphy-based FUR, the study was performed using severe ischemia in a mouse strain with combined immunodeficiency of B cells, T cells, and natural killer cells that is known to confer protection from ischemia-reperfusion injury based on current functional parameters .
Male severe combined immunodeficient [scid] beige mice, aged 10 weeks and weighing 22 to 24 g, were purchased from Charles River Laboratories (Sulzfeld, Germany). The animals were fed a standard diet and were allowed free access to water. All animal experiments were conducted in accordance with the institutional guidelines and were approved by the Administrative Panel on Laboratory Animal Care (Government of Upper Bavaria, Germany).
Renal ischemia-reperfusion injury model
Mice were anesthetized by intraperitoneal injection with a combination of 0.05 mg/kg fentanyl, 0.5 mg/kg medetomidine, 5 mg/kg midazolam and were placed on a heated surgical pad to keep a constant body temperature. The right kidney was exposed through a median abdominal incision, and the mice were subjected to ischemia by clamping the renal pedicle with a nontraumatic microaneurysm clamp (B. Braun Melsungen AG, Melsungen, Germany) which was removed after 40 min. The incision was closed with a 5-0 suture and surgical staples. Postoperatively, anesthesia was antagonized by intraperitoneal injection of a combination of 2.5 mg/kg atipamezole, 0.5 mg/kg flumazenil, and 1.2 mg/kg naloxone.
99mTc-MAG3 (Technescan MAG3, Covidien, Neustadt/Donau, Germany) imaging was performed in analogy to a previously described protocol . Briefly, after hydration with sterile saline and induction of anesthesia with a combination of 0.05 mg/kg fentanyl, 0.5 mg/kg medetomidine, and 5 mg/kg midazolam, the mice underwent whole-body scintigraphy using one detector of a triple-headed gamma camera (Philips - formerly Picker - Prism 3000XP, Cleveland, OH, USA) equipped with a low-energy high-resolution [LEHR] collimator. A LEHR collimator was favored over a pinhole collimator [PC] as PC provides higher resolution but at the cost of lower sensitivity. PC would be ideal for static imaging where the frame time could be lengthened. However, this study was a dynamic study with a frame time of only 5 s. The calculation of FUR utilizes the data pre-peak of the renogram, which usually occurs within the first 2 min of the study. High sensitivity in detection as well as resolutions is required to achieve a better signal to noise ratios.
Acquisition of a dynamic planar imaging study was started with the i.v. injection of a standardized dose of approximately 37 MBq of 99mTc-MAG3. One frame per 5 s was collected with a total scan time amounting to 10 min. The image acquisition magnification was set to ×4; after that, the scan anesthesia was antagonized as described above. To determine the baseline renal function, 99mTc-MAG3 imaging was carried out 4 days before the ischemia-reperfusion surgery. Postoperative renal scans were performed on days 8 and 14 for the assessment of early and long-term kidney functions.
Calculation of the fractional uptake rate
The FUR expresses the fraction of tracer in the blood taken up by the kidney per time unit as a measure of renal clearance. For the calculation of FUR, both kidney and cardiac curves were expressed in units of counts per second. The calculation was based on the equation previously proposed for patient studies , namely FUR = P(0) × (k l + k r)/ID, where k l and k r (per second) are the slopes of the linear uptake [LU] segment of the Patlak-Rutland [PR] plots for the left and right kidneys, respectively. P(0) (counts per second) is the value of the plasma clearance curve P(t) at time zero, and it can be obtained by back extrapolation using a mono-exponential fit to P(t). The range used for this exponential fit was chosen to be identical with the combined extent of the individually determined LU segments. In an independent study , this choice of fitting range for the mono-exponential method has been shown to yield optimal results. The injected dose [ID] (counts per second) was estimated from the whole body count rate averaged over the first minute of the study and corrected for any residual activity in the region of the injection site. The detection sensitivity of activity from both the kidneys and the injected dose were considered equal, and no correction for renal depth was applied. This approximation was felt to be justified on account of the small scale of the animal model and the consistency of both size and anatomy within the sample population studied. The calculation of FUR was performed with the aid of a user-written renal curve analysis software program (Renalcurve V3.0B1) made available by Hermes Medical Solutions (Stockholm, Sweden/London, UK). A feature of this program is that the theoretical relationship between the linear segment of the PR plot and the plateau level of the renal impulse retention function [IRF] is utilized to identify the LU segments. The IRF is obtained by deconvolution analysis using a constrained least square method. In order to improve the robustness of the linear fit to the LU segments, an estimate of the expected intercept is calculated from the IRF and included in the fitting process as an additional data point. The resultant values for FUR were expressed in units of percent injected dose per minute. In order to test for possible dependence of the FUR values on the ROI size or position, the image data from a subset of eight kidneys were re-analyzed independently.
Tissue specimens, i.e., ischemia-reperfusion-injured right kidneys and contralateral non-ischemic kidneys, were collected for histological analysis. After paraffin embedding, histological sections were stained with hematoxylin and eosin. Structural damage was assessed by histological analysis.
Statistical analysis was performed using paired or unpaired t test (two-sided). Our primary hypothesis was that ischemia-reperfusion decreases the kidney function measured by FUR. To test this hypothesis, FUR values were compared between post-ischemic and non-ischemic kidneys by paired t test. Data are expressed as mean ± SEM. P values < 0.05 were considered statistically significant.
Linear uptake segment
Differential renal function
The tables in Figure 3B illustrate the differential renal uptake function [DRF] which is calculated as the percentage contribution to total uptake from the left and right kidneys. Values for DRF were calculated over the uptake interval by three different methods, namely (a) from the integral of the background subtracted renograms, (b) from the slopes of the PR plots, and (c) from the heights of the plateau in the IRFs. A close agreement between the values obtained by these three methods served as an additional quality control measure. Values for FURL and FURR, corresponding to the left and right kidneys, were then calculated by multiplication of the total FUR by DRFL/100 and DRFR/100, respectively. Repeat FUR values were obtained as a quality control check. From the subset of eight kidneys, the repeat FUR values (range, 0.9 to 23.4%ID/min) showed a linear correlation with a linear correlation coefficient r = 0.99, mean difference 0.65 ± 1.2%ID/min and a non-significant paired t test (P > 0.10).
FUR for the determination of renal dysfunction following ischemia
Absolute FUR values and percentage of baseline values normalized to 100%
FURL (non-ischemic kidney)
FURR (40 min ischemia)
(% of baseline)
(% of baseline)
14.7 ± 0.6
18.5 ± 0.7
11.6 ± 1.4
10.3 ± 1.1
12.5 ± 1.6
12.8 ± 2.2
Ischemic kidneys of scid beige mice exhibited tubular dilatation and cytoplasmic degeneration as signs of hypoxia. Tissue viability was excellent with no signs of necrosis. In addition, no inflammatory infiltration was found (Figure 4C). Contralateral non-ischemic kidneys showed no signs of structural damage (Figure 4D).
A reproducible and functionally relevant experimental setup for preclinical therapy evaluation enhances the identification of effective treatment strategies and the successful translation into clinical practice. However, the preclinical model of renal ischemia-reperfusion injury exhibits only limited validity because standard parameters of kidney function were shown to drop to baseline levels within a few days after nonlethal bilateral ischemia-reperfusion injury . Most importantly, long-term effects as a result of the regenerative capability of the kidney and the efficacy of new therapeutic strategies remain unknown. Serum creatinine as the current gold standard indicator for renal dysfunction is mainly eliminated via glomerular filtration, but glomeruli are less susceptible to an event of ischemia-reperfusion, and tubular injury occurs before a decline in glomerular filtration is noted . Thus, the function of the tubules representing the most critically affected structures is not adequately reflected by these standard methods.
To facilitate the determination of pivotal functional long-term outcome, we aimed to overcome these limitations. The calculation of FUR allowed for the reproducible assessment of renal dysfunction following ischemic injury during long-term follow-up. In particular, using FUR, we were able to detect renal dysfunction in immunodeficient mice known to be virtually protected from ischemia-reperfusion injury. In the present murine model using male mice prior to surgery (baseline), the right kidney exhibited significantly higher absolute FUR values than the left kidney. In humans, likewise, a significantly higher mean split function of the right kidney among males was described . To our knowledge, this is the first study to report this unequal distribution of right and left renal function in the murine setting so far. As a consequence, the extent of renal dysfunction following injury is rather dependent on the initial baseline function depicted as the percentage of baseline values normalized to 100% on days 8 and 14 (Table 1). In reference to the baseline levels, a considerable functional decrease in the ischemic kidney was seen by day 8, although absolute values of FUR in the right ischemic kidney (FURR) and the left non-ischemic kidney (FURL) were quite similar during follow-up.
DRF and percentage of baseline values normalized to 100%
DRFL (non-ischemic kidney)
DRFR (40 min ischemia)
(% of baseline)
(% of baseline)
44.3 ± 0.8
55.7 ± 0.8
52.6 ± 1.2
47.4 ± 1.2
49.9 ± 1.6
50.1 ± 1.6
A significant difference is seen between the DRF of the right injured and the left non-ischemic kidneys on day 8 (Figure 2B), while for FUR, this is not the case. Considering renal dysfunction of the contralateral non-ischemic kidney, as seen from the flattening of the slope of the descending part of the renogram, FUR would be expected to decrease as seen in Figure 1. In contrast, DRF of the non-ischemic kidney increases on day 8, as compared with the baseline. This may be misleading as relative improvement of the renal function is not necessarily associated with increased absolute function. DRF provides only relative values depending on both kidneys that may lead to inadequate conclusions on individual renal function. In contrast, the determination of kidney function using FUR in longitudinal studies bears the advantage of comparison with the initial baseline data of the healthy kidney.
Despite the great advantages of the present protocol, there may be some technical limitations. The study lacks the correction for any possible difference in depths of the left and right kidneys below the skin surface. Any such difference in depth would lead to some asymmetry in the value of DRF (and FUR) to some degree. Assuming a value of 0.12 for the linear attenuation coefficient for 99mTc, one may estimate that a depth difference of 1.0 cm would result in a DRF ratio of 53%:47% (corresponding to a true ratio of 50%:50%). However, to obtain the observed distribution of 55.7%:44.3%, it would necessitate a depth difference of nearly 2.0 cm between the two kidneys which would seem unlikely for the small animal model.
FUR not only offers the advantage of expressing organ function in reference to tracer kinetics, but it has also been shown to be independent of patient size, gender, gamma camera, as well as time point and duration of examination . Given the various interindividual differences in mice, this proves to be useful in the murine model as well. Our overall experience from the present study is that when provided care and attention to detail is paid to the implementation, then FUR seems to be a potentially very useful parameter. Importantly, this study demonstrates that a conventional gamma camera is sufficient enough to achieve highly reliable functional data.
In the present experimental setup, we investigated the functional outcome following a severe ischemia time of 40 min. In scid beige mice, this extent of injury resulted in a comparatively moderate reduction of renal function. In immunocompetent wild-type mice, a much more pronounced decrease in kidney function would be expected with a histologically distinct post-ischemic inflammation . Histological findings in kidneys of scid beige mice were in accordance with the functional data. Tubules of ischemic kidneys only exhibited mild structural changes as signs of hypoxia without any evidence for severe damage. The absence of inflammatory infiltration in our model represents a feature of immunodeficient mice, supporting the notion of a severe ischemia-little injury model, and thus, the high reliability and sensitivity of the presented technique.
There are other important advantages of the utilized technologies. The assessment of standard renal function parameters requires kidney injury models using bilateral ischemia and unilateral ischemia with contralateral nephrectomy, respectively. The present technique enables the measure of relative renal function by the collection of separate data sets for the individual kidney so that injury may be limited to unilateral renal ischemia. Compensation of kidney function by the contralateral healthy kidney reduces morbidity and mortality while facilitating the use of severe injury models. It is important to note that ischemia times required for the desired tissue damage may vary depending on the utilized mouse strain. The clinical situation, of course, is often much more complicated. This type of acute unilateral kidney injury does not intend to represent a clinically realistic model. It rather serves as a simplified but useful model for future therapy evaluation in the field of kidney regeneration.
Bearing in mind the poor prognosis of patients with renal failure and the shortage of transplants, our data could be of considerable importance for the identification of novel treatment modalities to improve kidney allograft function and survival. Before any new treatment modality should be translated into a clinical setting, reliable preclinical studies are absolutely mandatory. Our model may aid to develop the respective studies and to reproducibly demonstrate the functional relevance of the investigated treatment regimen for renal and vascular regeneration.
A substantial part of this work originated from the doctoral thesis of Hao Wang. We are grateful to Heidi Zankl of the Department of Nuclear Medicine, University of Munich for her help and advice. This work was supported by a research grant from Novartis. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.
- Palm M, Lundblad A: Creatinine concentration in plasma from dog, rat, and mouse: a comparison of 3 different methods. Vet Clin Pathol 2005, 34: 232–236. 10.1111/j.1939-165X.2005.tb00046.xPubMedView ArticleGoogle Scholar
- Meyer MH, Meyer RA Jr, Gray RW, Irwin RL: Picric acid methods greatly overestimate serum creatinine in mice: more accurate results with high-performance liquid chromatography. Anal Biochem 1985, 144: 285–290. 10.1016/0003-2697(85)90118-6PubMedView ArticleGoogle Scholar
- O'Donnell MP, Burne M, Daniels F, Rabb H: Utility and limitations of serum creatinine as a measure of renal function in experimental renal ischemia-reperfusion injury. Transplantation 2002, 73: 1841–1844. 10.1097/00007890-200206150-00025PubMedView ArticleGoogle Scholar
- Roberts J, Chen B, Curtis LM, Agarwal A, Sanders PW, Zinn KR: Detection of early changes in renal function using 99mTc-MAG3 imaging in a murine model of ischemia-reperfusion injury. Am J Physiol Renal Physiol 2007, 293: F1408-F1412. 10.1152/ajprenal.00083.2007PubMed CentralPubMedView ArticleGoogle Scholar
- Rutland M, Que L, Hassan IM: "FUR"--one size suits all. Eur J Nucl Med 2000, 27: 1708–1713. 10.1007/s002590000337PubMedView ArticleGoogle Scholar
- Šámal M: The 14th international symposium on radionuclides in nephrourology. Semin Nucl Med 2011, 41: 3–10. 10.1053/j.semnuclmed.2010.09.004PubMedView ArticleGoogle Scholar
- Zhang ZX, Wang S, Huang X, Min WP, Sun H, Liu W, Garcia B, Jevnikar AM: NK cells induce apoptosis in tubular epithelial cells and contribute to renal ischemia-reperfusion injury. J Immunol 2008, 181: 7489–7498.PubMedView ArticleGoogle Scholar
- Kubinyi J, Nimmon C, Samal M, Kotalova D, Smidt V, Brabec V, Bergmann H: Improved gamma-camera method to calculate renal clearance using fractional renal uptake (FUR). Eur J Nucl Med Mol Imaging 2007,34(Suppl 2):S229.Google Scholar
- Fleming JS, Kemp PM: A comparison of deconvolution and the Patlak-Rutland plot in renography analysis. J Nucl Med 1999, 40: 1503–1507.PubMedGoogle Scholar
- Trof RJ, Di Maggio F, Leemreis J, Groeneveld AB: Biomarkers of acute renal injury and renal failure. Shock 2006, 26: 245–253. 10.1097/01.shk.0000225415.5969694.cePubMedView ArticleGoogle Scholar
- Clausen TD, Kanstrup IL, Iversen J: Reference values for 99mTc-MAG3 renography determined in healthy, potential renal donors. Clin Physiol Funct Imaging 2002, 22: 356–60. 10.1046/j.1475-097X.2002.00443.xPubMedView ArticleGoogle Scholar
- Nogueira JM, Weir MR, Jacobs S, Breault D, Klassen D, Evans DA, Bartlett ST, Cooper M: A study of renal outcomes in obese living kidney donors. Transplantation 2010, 90: 993–999.PubMedView ArticleGoogle Scholar
- Mansoor O, Chandar J, Rodriguez MM, Abitbol CL, Seeherunvong W, Freundlich M, Zilleruelo G: Long-term risk of chronic kidney disease in unilateral multicystic dysplastic kidney. Pediatr Nephrol 2011, 26: 597–603. 10.1007/s00467-010-1746-0PubMedView ArticleGoogle Scholar
- Bomanji J, Majeed F, Britton KE, Nimmon CC, Carroll MJ, Whitfield HN: Radionuclide evaluation pre- and post-extracorporeal shock wave lithotripsy for renal calculi. Contrib Nephrol 1987, 56: 256–60.PubMedView ArticleGoogle Scholar
- Herrler T, Tischer A, Meyer A, Feiler S, Guba M, Nowak S, Rentsch M, Bartenstein P, Hacker M, Jauch KW: The intrinsic renal compartment syndrome: new perspectives in kidney transplantation. Transplantation 2010, 89: 40–46. 10.1097/TP.0b013e3181c40abaPubMedView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.